![]() |
|
|
Vol. 303, Issue 1, 265-272, October 2002
Departments of Pharmacology (L.R., P.J.S.) and Anesthesiology (P.J.S.), Alcohol and Brain Research Laboratory, Texas Tech University Health Sciences Center, Lubbock, Texas
| |
Abstract |
|---|
|
|
|---|
The differential display of mRNA technique was used to screen the
expressed genes in control and 50 mM chronic ethanol-treated rat C6
glial cells, with and without activation by lipopolysaccharide (LPS)
combined with phorbol 12-myristate 13-acetate (PMA). One differentially
expressed transcript was identified as that corresponding to the
chemokine monocyte chemotactic protein (MCP)-3. MCP-3 is a broadly
active chemokine that functions in chemoattraction and activation of
monocytes, T lymphocytes, eosinophils, basophils, natural killer cells,
and dendritic cells. Steady-state MCP-3 mRNA levels were elevated
6-fold after 24-h stimulation of control cells but less than 3-fold
after stimulation of 9-day chronic ethanol-exposed cells. One- and
5-day exposures to 50 mM ethanol were not effective at reducing
steady-state MCP-3 mRNA levels in stimulated cells, whereas 1-day
exposure to >150 mM ethanol was effective. Stimulation with tumor
necrosis factor-
elevated MCP-3 mRNA in C6 glial cells to a
lesser extent than with LPS plus PMA, but the effects of ethanol were
consistent. To gain insight into possible mechanisms for
ethanol-induced reductions in steady-state MCP-3 mRNA, additional
studies examined nuclear MCP-3 RNA levels and MCP-3 mRNA degradation.
MCP-3 RNA content was greatly reduced in isolated nuclei from acute and
chronic ethanol-exposed cells, suggesting transcriptional inhibition. On the other hand, acute ethanol exposure enhanced degradation of
preexisting MCP-3 mRNA, indicating message destabilization. Thus, the
results are consistent with a dual mechanism for ethanol-induced reductions in steady-state MCP-3 mRNA levels.
| |
Introduction |
|---|
|
|
|---|
Chronic
or repeated exposure to alcohol can result in a variety of health
problems, including damage to the brain. Because the brain is
particularly susceptible to ethanol toxicity, understanding the
pathogenesis of alcohol-related brain damage becomes very important for
developing more effective treatments and preventative measures for
alcohol abuse. Glial cells are the most prevalent cell type in the
brain. Interactions between the numerous glial cells and neurons are
tantamount to a fully functional brain. Astrocytes are a crucial target
of ethanol during CNS development and are profoundly affected by
prenatal ethanol exposure. Ethanol can affect DNA, RNA, and protein
synthesis in primary cultures of rat cortical astrocytes and can
suppress astrocyte mitogenesis (Aroor and Baker, 1997
). Ethanol also
reduces the capacity of astrocytes to secrete growth factors (Valles et
al., 1994
), induces oxidative stress in astrocytes (Montoliu et al.,
1995
), and alters the development, content, and distribution of several
cytoskeletal proteins, including transcription of the astrocyte marker
glial acidic fibrillary protein (Valles et al., 1997
). Thus,
ethanol-induced alterations in astrocyte gene expression could be
important mechanisms underlying the CNS dysfunction observed after
prenatal exposure to ethanol (Guerri and Renau-Piqueras, 1997
). Chronic
alcohol abuse also affects adult glial cells. Human alcoholic brains
show clinical and pathological evidence of significant astrocyte
activation and glial cell loss in both gray and white matter regions
(Hunt and Nixon, 1993
; Korbo, 1999
).
It is likely that chronic ethanol effects on astrocyte gene expression
play a role in the pathogenesis of alcohol-related brain damage.
Identity of these genes and their products can provide insight into the
etiology of alcohol-related brain damage and possibly alcoholism
itself. Genes that play a role in host defense mechanisms may be
particularly important targets related to the pathophysiology of
alcohol abuse and alcoholism (Cook, 1998
); however, there is a paucity
of data regarding alcohol and CNS host defense genes and mechanisms.
We have previously demonstrated that the inducible nitric-oxide
synthase is one host defense gene in the astrocyte-derived C6 cell line
susceptible to ethanol exposure (Syapin, 1995
; Militante et al., 1997
;
Syapin et al., 2001
). To identify additional ethanol-responsive genes
potentially related to host defense mechanisms and alcohol-related brain damage, we have used differential display of mRNA (Liang and
Pardee, 1992
) to screen the expressed genes in chronic ethanol-treated rat C6 glial cells after activation with bacterial LPS combined with
PMA. With this technique we have detected several differentially regulated genes possibly involved in altered CNS host defense mechanisms or other responses to chronic ethanol (L. Ren and P. J. Syapin, unpublished data), including unsuspected genes such as that
coding for fibronectin (Ren et al., 2000
).
In this article, we report our findings on an important host defense
gene whose expression is differentially regulated by acute and chronic
ethanol exposure in activated C6 glial cells, the chemokine MCP-3.
Chemokines are low-molecular-weight secreted proteins and represent a
subfamily of cytokines with strong chemotactic activity produced in
response to proinflammatory signals such as LPS, TNF
, and
interleukin-1
. MCP-3 is a member of the CC or
-chemokine
subfamily that includes the closely related MCP-1, MIP-1
, and
regulated upon activation normal T cell expressed and secreted.
MCP-3 is a broad-spectrum chemokine, being chemotactic for monocytes,
lymphocytes, eosinophils, basophils, natural killer cells, and
dendritic cells (Rollins, 1997
). Inducible expression of MCP-3 by
astrocytes has been documented previously (Hesselgesser and Horuk,
1999
; Hua and Lee, 2000
), but we are unaware of any studies
demonstrating interactions of MCP-3 expression with ethanol exposure in
astrocytes or any other cell type. Given the large number of cells that
are attracted by MCP-3, its suppression by ethanol would be expected to
severely dampen immune and inflammatory responses, an effect that may
contribute to the pathogenesis of alcohol-related brain damage.
| |
Materials and Methods |
|---|
|
|
|---|
Cell Culture.
Stock cultures of C6 glioma cells (Benda et
al., 1968
) were originally obtained from the American Type Culture
Collection (Manassas, VA) and cultured using methods and supplies
described previously (Syapin, 1995
; Militante et al., 1997
). In brief,
cultures were grown in high glucose-containing Dulbecco's modified
Eagle's medium with 5% (v/v) fetal bovine serum added. Experimental
cultures were plated at the appropriate cell density for their intended time of growth as described in Syapin (1995)
and grown in medium containing 2.5% (v/v) fetal bovine serum. All cultures were maintained at 37°C inside humidified incubators with 5%
CO2, 95% air. Culture medium was replenished 2 to 3 days after seeding and every other day thereafter, unless
otherwise noted.
Ethanol Treatment.
Cells were treated with ethanol as for
previous studies (Syapin et al., 1999
, 2001
; Ren et al., 2000
).
Concentrations used for acute exposure were from 50 to 300 mM. Chronic
exposure was to 50 mM ethanol. Chronic treatment began upon initiating
the experimental cultures and continued for up to 9 days before cell activation and sample collection. The cultures were grown in 1.8-liter sealed rectangular storage containers (Rubbermaid, Wooster, OH) containing a 300-ml reservoir of aqueous ethanol at the same
concentration as in the medium. The atmosphere inside the containers
was equilibrated with compressed 5% CO2/95% air
just before sealing and placement inside a water-jacketed 37°C
CO2 incubator. Control cells were handled the
same way except the reservoir contained only water.
Cell Activation.
LPS (Escherichia coli;
Sigma-Aldrich, St. Louis, MO) stock solutions were prepared at 1 mg/ml
in cartridge-purified deionized water, filter-sterilized, and stored
frozen at
20°C. An LPS working solution (50 µg/ml) was prepared
from the stock into fresh assay medium (serum-free Dulbecco's modified
Eagle's medium) and used within the hour. Stock PMA (Sigma-Aldrich)
was dissolved in acetone (Fisher Scientific, Houston, TX) at 0.5 mg/ml
and stored at
20°C. The PMA working solution (40 µg/ml) was
prepared fresh on ice into assay medium under subdued lighting and used
immediately thereafter. The low level of acetone added to the cells as
vehicle was tested and found not to affect the response. C6 glial cells were activated by simultaneous exposure to 500 ng/ml LPS and 400 ng/ml
PMA, as described previously (Syapin, 1995
; Militante et al., 1997
).
Activation was initiated by removing the growth medium, rinsing the
culture dish once with assay medium, adding fresh assay medium, and
then adding aliquots of the LPS and PMA. For cells exposed to ethanol,
the assay medium contained the appropriate ethanol concentration during
all steps and the subsequent 24-h incubation. Controls consisted of
unstimulated cells exposed and not exposed to ethanol. Human
recombinant TNF
(Collaborative Biomedical Products, Bedford, MA)
stock solutions (6 µg/ml) were prepared in sterile phosphate-buffered
saline containing 0.2% bovine serum albumin (Sigma-Aldrich) and stored
at 4°C. An aliquot of the TNF
stock solution was diluted 1:1 (v/v)
with assay medium and added to a final concentration of 30 ng/ml.
Exposure to the stimulating agents was for 24 h in this study.
mRNA Differential Display.
The isolation of total cellular
RNA, treatment with DNase I, and performance of the reverse
transcription and polymerase chain reaction for differential display
were performed exactly as described previously (Ren et al., 2000
).
Briefly, we used the HIEROGLYPH mRNA profile kit, the FluoroDD
TMR-fluorescent-anchored primer adapter kit for the HIEROGLYPH mRNA
profile kit system, a Genomyx LR programmable DNA sequencer, and a
Genomyx SC fluorescence scanner (Beckman Coulter, Inc., Fullerton,
CA). Conditions for electrophoresis and gel band reamplification
were exactly as described previously (Ren et al., 2000
). The
reamplified PCR product was used as the template for direct DNA
sequencing on an ABI prism genetic analyzer (PerkinElmer Life Sciences,
Boston, MA).
RT-PCR Analysis of MCP-3 mRNA from Total RNA.
Total RNA was
extracted using the guanidinium isothiocyanate procedure (Chomczynski
and Sacchi, 1987
). Aliquots (0.2 µg) of RNA from each treatment group
were reverse transcribed with random primers (Promega, Madison, WI) and
1 µl of the cDNA mixture was subjected to PCR using specific
oligonucleotide primers (5'-GGT ACC ACT CTC TTT CTC CAC CAT G-3' and
5'-AAG CTT ACA GCG GTG AGG AAT TTT GC-3') shown previously to detect
rat MCP-3 mRNA (Natori et al., 1997
). The same cDNA mixture was also
subjected to PCR in a separate tube using a pair of primers (5'-ACG TCA
ACA CTG CTC TAC A-3' and 5'-CTT TGC CAT AGT CCT TAA C-3') specific for ribosomal S12 RNA (Ayane et al., 1989
). The expected size of the amplification products was 370 base pairs for MCP-3 and 311 base pairs
for S12. A number of PCR cycles and denaturation temperatures were
examined with scanning densitometry to ascertain a linear working range
for both PCR products. After electrophoretic separation on agarose,
ethidium bromide-stained gels were photographed with a Polaroid camera
system. Quantification was achieved by band densitometry of
photographed gels using an Alpha imager (Alpha Innotech Corporation,
San Leandro, CA) followed by normalization to the corresponding S12
ribosomal protein cDNA band density as reported previously (Ren et al.,
2000
). S12 mRNA served as an internal standard to verify whether equal
quantities of cDNAs were amplified and allowed for an estimation of the
integrity of the extracted RNA. This abundant RNA does not seem to
change significantly upon addition of ethanol or LPS plus PMA to
cultured C6 cells and is adequately stable (Fig. 7B). Significant
within-group biological variation in the MCP-3 response to stimuli was
seen in some experiments (Fig. 3B), leading to larger than usual
standard errors.
RT-PCR Analysis of MCP-3 mRNA from Nuclear RNA.
Nuclei
isolation, nuclear run-on transcription using nonradioactive dNTPs, and
extraction and precipitation of nuclear RNA were carried out according
to standard procedures (Greenberg and Bender, 1997
). After the reverse
transcription of nuclear RNA, PCR analysis was used to detect MCP-3
mRNA with normalization to S12 mRNA as described above.
Determination of MCP-3 mRNA Stability.
To measure RNA
stability, control cultures were first stimulated with LPS plus PMA for
24 h to induce MCP-3 mRNA expression. After induction, the media
were removed from the cultures, and they were rinsed once with fresh
37°C assay medium. This was followed by application of new assay
medium containing 25 µg/ml 5,6-dichlorobenzimidazole riboside (DBR),
an inhibitor of mRNA synthesis (Tamm et al., 1976
). The cultures were
then placed in individual storage containers, equilibrated with 5%
CO2, 95% air, and returned to the incubator as
described under "Ethanol Treatment". To examine the effect of
ethanol on RNA stability, the stimulated cultures were separated into
control and ethanol-treated groups. The ethanol-treated group was
handled in the same way as the controls except the assay medium and
reservoir inside the storage containers contained 200 mM ethanol. At
designated times after DBR addition control and ethanol-treated cultures were removed from the incubator and processed as described under "RT-PCR Analysis of Total RNA". The DBR (Sigma-Aldrich or ICN
Pharmaceuticals Biochemicals Division, Aurora, OH) was prepared as a
12.5-mg/ml stock solution in dimethyl sulfoxide (Sigma-Aldrich) and
stored at
20°C between uses.
| |
Results |
|---|
|
|
|---|
Differential Display of MCP-3 mRNA in LPS/PMA-Stimulated C6
Cells.
The differential display of mRNA technique (Liang and
Pardee, 1992
) was used to isolate genes that are up- or down-regulated in chronic 50 mM ethanol-treated rat C6 glial cells with and without activation by LPS/PMA. One of the mRNAs found to be regulated under
these conditions was a cDNA referred to as band 20C42 (Fig. 1). This band was detected using the
TMR-anchored primer 5'-ACG ACT CAC TAT AGG GCT TTT TTT TTT TTG G-3' and
the arbitrary primer 5'-ACA ATT TCA CAC AGG AGA CCA TTG CA-3' in the
RT-PCR. After reamplification of this band, sequence analysis of the
PCR product revealed 96% nucleotide sequence identity in a 430-base
pair fragment that overlapped the 3' end of the rat MCP-3 mRNA sequence
(Wang et al., 1999
). This result clearly indicated that this
differentially expressed cDNA corresponded to that of the rat MCP-3
transcript. Figure 1 is from the differential display gel. It shows
that expression of this mRNA was markedly increased by 24 h
LPS/PMA stimulation of control C6 cells. In addition, it shows that 9 days of chronic exposure to 50 mM ethanol before LPS/PMA stimulation
seemed to significantly reduce its expression.
|
Time Course of LPS/PMA-Stimulated MCP-3 mRNA Expression in Chronic
Ethanol-Treated C6 Glial Cells.
To confirm the differential
display data and to obtain further information on 50 mM ethanol effects
on MCP-3 mRNA expression in C6 glial cells, we compared expression
levels in control cells and cells exposed to 50 mM ethanol for 1, 5, and 9 days with and without stimulation with LPS/PMA. For these and all
subsequent studies specific MCP-3 primers were used during PCR (see
Materials and Methods). As shown in Fig.
2, chronic 50 mM ethanol treatment for 9 days significantly decrease normalized MCP-3 mRNA expression in
LPS/PMA-stimulated C6 glial cells (P < 0.05), whereas
basal expression in unstimulated cells was unchanged by chronic ethanol exposure.
|
Dose-Dependent Effects of Ethanol on MCP-3 mRNA Expression during
24-h LPS/PMA Stimulation.
As can be seen from the previous results
(Fig. 2), 1 and 5 days of exposure to 50 mM ethanol did not reduce
MCP-3 mRNA expression in LPS/PMA-stimulated C6 glial cells. Because the
1-day ethanol exposure coincided with the 24-h LPS/PMA stimulation,
this treatment was equivalent to an acute ethanol exposure. Further
investigations were aimed at identifying acute effects of ethanol on
MCP-3 mRNA expression in C6 glial cells. Therefore, C6 cells were
stimulated with LPS/PMA in the presence of 0, 50, 100, 150, 200, and
300 mM concentrations of ethanol, followed 24 h later by RT-PCR
analysis of total RNA to measure MCP-3 mRNA in the cells. As shown in
Fig. 3, acute treatment with 50, 100, and
150 mM ethanol could not significantly alter LPS/PMA-stimulated MCP-3
mRNA expression, whereas statistically significant inhibition was
observed at 200 and 300 mM concentrations.
|
Effect of Acute and Chronic Ethanol Exposure on TNF
-Stimulated
MCP-3 mRNA Expression.
TNF
is a cytokine that can also
stimulate MCP-3 mRNA expression in C6 glial cells. To determine whether
the effects of ethanol are stimulus-specific, we also performed acute
and chronic ethanol exposure studies on cells activated by TNF
. Data
for acute ethanol experiments are shown in Fig.
4. The results are virtually identical to
those obtained when LPS/PMA was used to induce MCP-3 mRNA (compare Figs. 3 and 4). Ethanol concentrations of 200 mM and greater elicited a
statistically significant reduction in normalized MCP-3 mRNA. As seen
previously, ethanol had no effect on basal MCP-3 mRNA levels.
Additional studies indicated that exposure to IL-1
(2 ng/ml) also
induced MCP-3 mRNA expression and that acute treatment with 200 mM
ethanol was able to inhibit this induction (data not shown).
|
|
Effect of Ethanol on MCP-3 Nuclear Gene Transcription.
To
investigate whether the suppressive effect of acute and chronic ethanol
on total cellular MCP-3 mRNA induction was due to changes in
transcriptional activity, we examined MCP-3 RNA levels in isolated
nuclei. We followed procedures for the standard nuclear run-on
transcription assay, but used RT-PCR to detect the transcripts rather
than membrane hybridization. As shown in Fig.
6A, MCP-3 RNA transcripts were greatly
reduced in nuclei isolated from cells acutely exposed to 200 mM ethanol
during stimulation. When the experiment was repeated using cells
chronically exposed to 50 mM ethanol for 9 days, identical results were
obtained (Fig. 6B). The effect of acute and chronic ethanol exposure on
nuclear MCP-3 RNA was very pronounced. In fact, there were no
statistical differences between stimulated and unstimulated values from
ethanol-exposed cells. This is in contrast to the control group where
the nuclear content of MCP-3 RNA was significantly increased by LPS/PMA
stimulation.
|
Effect of Acute Ethanol on MCP-3 mRNA Stability.
Experiments
were also performed to determine whether ethanol had any direct effects
on the stability of MCP-3 mRNA. Control cultures were stimulated with
LPS/PMA for 24 h to enhance MCP-3 mRNA levels, followed by
treatment with the adenosine analog DBR to inhibit further mRNA
synthesis. Ethanol (200 mM) was added along with the DBR to examine its
effects. MCP-3 mRNA levels were determined every 3 h over a 12-h
period. As seen in Fig. 7A, normalized MCP-3 mRNA levels were relatively unchanged in control cells over the
12-h post-DBR, whereas acute ethanol exposure led to significant degradation by 9- and 12-h post-DBR. These results suggest that posttranslational stabilization of MCP-3 message occurs after LPS/PMA
exposure and that acute ethanol can disrupt the stabilization process.
|
| |
Discussion |
|---|
|
|
|---|
To gain a more comprehensive understanding of ethanol-mediated gene regulation in activated astroglial cells, we used the technique of mRNA differential display to isolate LPS/PMA-induced transcripts whose expression seemed modulated in rat C6 glial cells by chronic exposure to 50 mM ethanol. The C6 glial cell line was used because it possesses extensive chemical and functional analogy to normal rat brain astrocytes and has served as a useful astroglial cell model for decades, including studies on acute and chronic ethanol effects. Also, its clonal nature affords very reproducible results, an important advantage for mRNA profiling studies. Herein, we report having identified the chemokine MCP-3 as one such gene whose mRNA expression is increased by LPS/PMA stimulation in C6 cells and decreased by ethanol exposure. To our knowledge, this is the first description of an effect of ethanol on MCP-3 expression.
MCP-3 is a member of the chemokine superfamily of mediators involved
mainly in the immune and inflammatory process (Oppenheim et al., 1991
;
Baggiolini et al., 1994
) but serves other functions as well (Luster,
1998
). Astrocytes can secrete numerous cytokines, including chemokines
such as MCP-3, and it is widely accepted that these cells actively
participate in an integrative communicative pathway between resident
immune cells of the CNS and those of the periphery (Aschner, 1998
).
Thus, chemokine expression by astrocytes may contribute to leukocyte
infiltration within the CNS during injury and inflammation.
The present results are the first to demonstrate an effect of ethanol
on expression of the
-chemokine MCP-3. However, previous studies
have observed ethanol effects on related members of the
-chemokine
family. For example, acute ethanol consumption attenuated ex vivo
stimulation of interleukin-8 and MCP-1 induction by human leukocytes
(Szabo et al., 1999
), whereas Kupffer cells isolated from rats injected
with ethanol and LPS had reduced MIP-1
and MCP-1 mRNA expression
(Bautista, 2001
). Interestingly, LPS-induced Kupffer cell expression of
mRNA for the
-chemokine regulated upon activation normal T cell
expressed and secreted was enhanced by ethanol under the same
conditions (Bautista, 2001
). Consistent with the present results,
LPS-induced expression of MIP-1
was attenuated in murine alveolar
macrophages after chronic ethanol exposure (Standiford and Danforth,
1997
), whereas expression profiling using DNA microarrays identified
MCP-1 as an ethanol-responsive gene that is down-regulated after
chronic exposure of human SH-SY5Y neuroblastoma cells to 100 mM ethanol
(Thibault et al., 2000
). Interestingly, chronic ethanol consumption has
been found to increase selected hepatic cytokines (Tilg and Diehl,
2000
), including the
-chemokines MCP-1, MIP-1
, and MIP-1
(Afford et al., 1998
). Therefore,
-chemokines seem to be important
cellular targets of both in vivo and in vitro ethanol exposure.
Ethanol treatment seemed to transcriptionally inhibit stimulated
expression of the MCP-3 gene, based on reductions in nuclear MCP-3 mRNA
levels. However, the sensitivity of inducible MCP-3 expression to
chronic ethanol exposure seems to be less than that of two other
inducible genes previously studied under identical conditions, those
for fibronectin (Ren et al., 2000
) and iNOS (Syapin, 1995
). For both
fibronectin and iNOS, we observed significant reductions in
steady-state mRNA levels after just 5 days of chronic exposure to 50 mM
ethanol (Ren et al., 2000
; P. J. Syapin, unpublished data),
whereas 5 days of exposure did not significantly reduce MCP-3 mRNA.
However, levels for all three transcripts are significantly reduced
with 9 days of chronic exposure. Interestingly, inducible expression of
MCP-3 and fibronectin mRNA is similarly sensitive to acute ethanol
exposure, with both requiring at least 200 mM ethanol for inhibition.
This contrasts with the acute sensitivity of iNOS mRNA to as little as
100 mM ethanol (Militante et al., 1997
). The explanation for, and
consequences of, this divergent sensitivity of host defense-related
genes to ethanol exposure remain to be determined.
A possible explanation for the differential sensitivity of MCP-3 expression to ethanol exposure, relative to that of iNOS and fibronectin, may relate to differences in regulatory mechanisms that govern their expression. Because the identical stimulus, LPS/PMA exposure, can be used to induce expression of MCP-3, fibronectin, and iNOS genes in C6 cells, the observed differences in ethanol sensitivity cannot be readily explained by differences in ethanol effects on signal transduction events. Rather, differences in the trans- and cis-acting elements necessary for transcriptional regulation of the individual genes may dictate their sensitivity to ethanol.
To explore this possibility further we have used the program Tfsitescan
(http://www.ifti.org) to analyze the nucleotide sequences of the rat
MCP-3, fibronectin, and iNOS gene promoter regions acquired from
GenBank (accession number AF154245, X05831, and AF042085, respectively)
to identify known cis regulatory elements. For this analysis
the iNOS region was restricted to the proximal 526 bases upstream of
the transcriptional start site because we have recently shown this
region to be sufficient to mediate the transcriptional inhibition of
iNOS expression by acute ethanol (Syapin et al., 2001
). Well over 40 putative cis-regulatory sites were identified in each
promoter region, but only 13 different elements, including three for
the basal transcription machinery, were common among the three promoter
regions. Six additional cis-elements of diverse sequence
reported to bind similar trans-acting factors were also
identified. Thus, from this in silico analysis there are a large number
of putative regulatory sites that may confer sensitivity or resistance
to ethanol effects on expression of these three inducible genes. It is
interesting, however, that only the iNOS and fibronectin promoters
share binding sites for the transcription factor cAMP response
element-binding protein, which has been implicated to play a role in
chronic effects of ethanol (Yang et al., 1998
). Furthermore, both the
rat iNOS and fibronectin promoters possess the C-to-T genetic variant
of the Sp1 binding cis-element that was previously
implicated in alcoholism (Harada et al., 1998
). Thus, it is evident
that further studies are necessary to identify those transcription
factors that mediate ethanol effects on inducible gene expression.
In addition to an apparent effect on MCP-3 transcription, acute ethanol
treatment also decreased MCP-3 transcript stability measured 24 to
36 h after induction. Whether MCP-3 transcripts are similarly
labile after chronic ethanol exposure has been difficult to determine
because expression levels at 24 h of stimulation are already low
after chronic exposure. However, preliminary data from one experiment
suggests that it is also more labile (P. J. Syapin, unpublished
data). The mechanism responsible for ethanol-induced MCP-3
destabilization is not known. The 3'-untranslated region of the rat
MCP-3 transcript is known to contain two A+U-rich elements (ARE)
associated with mRNA stabilization (Xu et al., 1997
), but their
functionality has not been documented. Even though our results provide
the first evidence for stabilization of the MCP-3 message after
stimulated induction in control cells, the data do not directly link
the ARE to this process. Further study is required to understand the
role of ARE in MCP-3 message stability and whether ethanol interacts
with the function of these sites.
In conclusion, using the technique of differential display of mRNA we have discovered that MCP-3 mRNA expression is up-regulated by LPS plus PMA exposure in C6 glial cells and that chronic ethanol exposure can reduce this expression. We have characterized this response further and provide evidence for a dual mechanism whereby acute ethanol exposure reduces steady-state MCP-3 mRNA levels. The specific consequences of this effect are unclear at this time, but may result in altered immune cell CNS trafficking after injury or infection of ethanol-intoxicated individuals.
| |
Footnotes |
|---|
Accepted for publication June 14, 2002.
Received for publication February 26, 2002.
This work was supported by National Institutes of Health Grant AA11643 and the Texas Advanced Research Program under Grant 010674-011.
DOI: 10.1124/jpet.102.035253
Address correspondence to: Dr. Peter J. Syapin, Department of Pharmacology, Texas Tech University Health Sciences Center, 3601 4th St., Lubbock, TX 79430-0001. E-mail: peter.syapin{at}ttmc.ttuhsc.edu
| |
Abbreviations |
|---|
CNS, central nervous system; PMA, phorbol 12-myristate 13-acetate; MCP, monocyte chemotactic protein; LPS, lipopolysaccharide; TNF, tumor necrosis factor; MIP, macrophage inflammatory protein; PCR, polymerase chain reaction; RT-PCR, reverse transcription-polymerase chain reaction; DBR, 5,6-dichlorobenzimidazole riboside; RANTES, regulated upon activation normal T cell expressed and secreted; IDV, integrated density value; iNOS, inducible nitric-oxide synthase; ARE, A+U-rich element; ANOVA, analysis of variance.
| |
References |
|---|
|
|
|---|
CXC and CC chemokines.
Adv Immunol
55:
97-179[Medline].
a review.
Alcohol Clin Exp Res
22:
1927-1942[Medline].
chemotactic cytokines that mediate inflammation.
N Engl J Med
338:
436-445
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||